Sign in Subscribe
Cancer metastasis

Spinal Surgery Improves Daily Activities in Patients with Metastatic Spinal Tumors

Strategic Insights

— 2 min read

Research from the Department of Orthopaedic Surgery in Osaka, Japan, investigated the effects of spinal surgery on the activities of daily living (ADL) in patients with metastatic spinal tumors. According to the study, which analyzed 404 symptomatic patients who underwent surgical treatment, spinal surgery can improve ADL in patients with spinal metastases. However, not all patients experience favorable outcomes.

The research, published in The Spine Journal, found that preoperative factors such as the severity of paralysis, ADL impairment, laboratory data, and treatment history were significant predictors of ADL after surgery. The study also identified risk factors for poor postoperative improvement, including a preoperative ECOG-PS score of 3, history of systemic therapy, primary tumor type, anemia, and high C-reactive protein/albumin ratio.

Key Takeaways:

  • Spinal surgery can improve ADL in patients with metastatic spinal tumors, but not all patients experience favorable outcomes.
  • Preoperative factors such as the severity of paralysis, ADL impairment, laboratory data, and treatment history were significant predictors of ADL after surgery.
  • A preoperative ECOG-PS score of 3 was associated with poor postoperative improvement.
  • History of systemic therapy, primary tumor type, anemia, and high C-reactive protein/albumin ratio were also associated with poor postoperative improvement.
  • The study involved 404 symptomatic patients who underwent surgical treatment for metastatic spinal tumors.
  • The research was conducted by the Department of Orthopaedic Surgery in Osaka, Japan, and was published in The Spine Journal.
  • The study's findings indicate that spinal surgery can be an effective treatment option for patients with metastatic spinal tumors.

Statistics:

  • 404 symptomatic patients were involved in the study, all of whom underwent surgical treatment for metastatic spinal tumors.
  • The study analyzed changes in ECOG-PS and Barthel Index (BI) scores preoperatively and at 1 and 6 months post-surgery.
  • At 1 month post-surgery, 46.9% of patients with a ECOG-PS score of 2 received systemic therapy, compared to 12.5% of those with a ECOG-PS score of 3.
  • Preoperative factors associated with poor postoperative improvement at 1 month included no use of bone-modifying agents, Frankel grade C, ECOG-PS score of 3, and high C-reactive protein/albumin ratio.
  • Preoperative factors associated with poor postoperative improvement at 6 months included history of systemic therapy, primary tumor type, anemia, and high C-reactive protein/albumin ratio.

Sources:

  • NewsRx. Recent Studies from Department of Orthopaedic Surgery Add New Data to Medical Devices and Surgical Technology (Changes in Performance Status and Predictive Factors for Poor Improvement Following Surgery for Spinal Metastasis: A Nationwide ...). Medical Devices & Surgical Technology Week. November 2, 2025; p 1245.
  • Changes in Performance Status and Predictive Factors for Poor Improvement Following Surgery for Spinal Metastasis: A Nationwide Multicenter Prospective Cohort Study. The Spine Journal, 2025.

Read more